Evaluates an injectable hydrogel as a vitreous substitute, highlighting its potential for ocular diseases.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: